F
Flame Biosciences
Biotech & Life Sciences · New York City, United States · Founded 2017
Flame Biosciences | Inflammasome Therapies Research, Development, and Commercialization MoreLess
Flame Biosciences is a biotechnology company focused on developing high-value medicines in the emerging area of inflammasome science. The company specializes in research, development, and commercialization of therapies aimed at treating cancer and other diseases driven by inflammation. Flame Biosciences operates in the pharmaceutical and biotechnology market, serving patients who suffer from oncology and inflammatory conditions. The business model revolves around creating a pipeline of best-in-class assets with the potential to make a significant positive impact on patient health. Revenue is generated through the development and commercialization of these innovative therapies, as well as through strategic partnerships and financing activities. The company recently announced a $100 million common stock financing to further advance its drug development initiatives.
Keywords: biotechnology, inflammasome, oncology, inflammation, drug development, high-value medicines, research, commercialization, financing, pipeline.
Company overview
Flame Biosciences company information
The essential company record, classifications and operating signals in one place.
- Status
- Acquired
- Founded
- 2017
- Headquarters
- New York City, United States
- Employees
- 1
- Open positions
- None listed
- Dealroom signal
- 24.3
Valuation & funding
Flame Biosciences funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Jan 2023 | $0 | — | Leap Therapeutics | ↗ |
| EARLY VCOther financing | Oct 2020 | $100M | $400M | Adage Capital · Rock Springs Capital · Citadel · Cormorant Asset Management | — |
Growth signals
Flame Biosciences website traffic
Latest recorded traffic for Flame Biosciences is 410 monthly website visits, down 31.7% over the last three months.
Comparisons
Flame Biosciences compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Flame Biosciences's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Flame Biosciences has talent and traffic
In the news
Latest news about Flame Biosciences
Recent press, funding announcements, and product moves mentioning Flame Biosciences — open to read from the original sources.
Market sentiment
What the market is saying about Flame Biosciences
An AI-synthesized read of the highest-engagement posts about Flame Biosciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Flame Biosciences’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.